Elizabeth Cermak
CIK 1471971 · EVP, Chief Commercial Officer · last filed 2025-11-14
Elizabeth Cermak is an EVP, Chief Commercial Officer who has filed 19 SEC Form 4 insider transactions across 4 companies since 2009. The most recent filing, for MBRX, was dated Nov 14, 2025. Across all open-market trades the lifetime net is +$46.7K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
19
$46.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MBRX | Director | — | $2.64 | — | $0 | 6 | 2025-11-14 |
| Clarus Therapeutics Holdings, Inc. (CRXTW) Delisted | Director | 5,766 | $0.01 | $78 | $0 | 2 | 2022-06-09 |
| SteadyMed Ltd. (STDY) Delisted | Director | — | — | — | $0 | 3 | 2017-12-28 |
| POZEN INC /NC (POZN) Delisted | EVP, Chief Commercial Officer | 20,000 | — | — | $46.7K | 7 | 2013-03-15 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-11-14 | MBRX | Grant (A) | — | $0 | EDGAR |
| 2024-11-06 | MBRX | Grant (A) | — | $0 | EDGAR |
| 2023-05-26 | MBRX | Grant (A) | — | $0 | EDGAR |
| 2022-06-22 | MBRX | Grant (A) | — | $0 | EDGAR |
| 2022-06-09 | Clarus Therapeutics Holdings, Inc. (CRXTW) Delisted | Grant (A) | +1,922 | $0 | EDGAR |
| 2021-12-14 | Clarus Therapeutics Holdings, Inc. (CRXTW) Delisted | Grant (A) | +3,844 | $0 | EDGAR |
| 2021-06-09 | MBRX | Grant (A) | — | $0 | EDGAR |
| 2020-10-05 | MBRX | Grant (A) | — | $0 | EDGAR |
| 2018-09-04 | — | Other (J) | — | $0 | |
| 2017-12-28 | SteadyMed Ltd. (STDY) Delisted | Grant (A) | — | $0 | EDGAR |